On January 25, 2023, in order to address current working capital requirements of Celularity Inc., or Celularity, Robert Hariri, M.D., Ph.D., Celularitys Chairman and Chief Executive Officer, agreed to temporarily suspend payment of salary pursuant to his employment agreement until as late as December 31, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | -1.43% | -8.20% | +13.18% |
1st Jan change | Capi. | |
---|---|---|
+13.18% | 60.99M | |
+16.85% | 122B | |
+19.63% | 113B | |
+18.20% | 26.49B | |
-23.38% | 19.4B | |
-19.03% | 16.24B | |
-20.21% | 15.4B | |
-45.95% | 15.15B | |
+62.13% | 14.93B | |
+3.46% | 13.52B |
- Stock Market
- Equities
- CELU Stock
- News Celularity Inc.
- Celularity Inc. Announces the Suspends of Robert Hariri as Chief Executive Officer